跳至主要内容
临床试验/PACTR202402605784366
PACTR202402605784366招募中2 期

Amitriptyline versus nutraceuticals in the prophylaxis of vestibular migraine: randomized controlled study

Faculty of mediicne Menoufia university hospitals0 个研究点目标入组 60 人开始时间: 2024年1月27日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with vestibular migraine according to the diagnostic criteria of the International Classification of Headache Disorders (ICHD diagnostic criteria, 2018).
  • -patients in the age range of 18 to 60 years either males or females.
  • - Available method of communication like email ,cell phone or whatsaap.

排除标准

  • 1-Patients with a known history of allergic reaction to amitriptyline ,co enzyme 10 .riboflavin and magnusuim
  • 2-Patients with a significant illness or medical condition such as cancer, cardiac diseases,neuropychiatric disorders ,liver, or kidney failure.
  • 3-Patients with history of gastrointestinal distrbances that affect absorption and metabolism of drugs.
  • 4- Pregnant or lactating females.

研究者

发起方
Faculty of mediicne Menoufia university hospitals

相似试验

Amitriptyline versus nutraceuticals in vestibular... | 临床试验